These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30137251)

  • 1. Trends in Treatment Uptake and Provider Specialty for Hepatitis C Virus (HCV) Infection in the Veterans Affairs Healthcare System: Results From the Electronically Retrieved Cohort of HCV-Infected Veterans (ERCHIVES).
    Butt AA; Yan P; Lo Re Iii V; Shaikh OS; Ross DB
    Clin Infect Dis; 2019 Feb; 68(5):857-859. PubMed ID: 30137251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C Virus (HCV) Treatment With Directly Acting Agents Reduces the Risk of Incident Diabetes: Results From Electronically Retrieved Cohort of HCV Infected Veterans (ERCHIVES).
    Butt AA; Yan P; Aslam S; Shaikh OS; Abou-Samra AB
    Clin Infect Dis; 2020 Mar; 70(6):1153-1160. PubMed ID: 30977808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population approach to disease management: hepatitis C direct-acting antiviral use in a large health care system.
    Belperio PS; Backus LI; Ross D; Neuhauser MM; Mole LA
    J Manag Care Spec Pharm; 2014 Jun; 20(6):533-40. PubMed ID: 24856591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C Cure Is Associated with Decreased Healthcare Costs in Cirrhotics in Retrospective Veterans Affairs Cohort.
    Maier MM; Zhou XH; Chapko M; Leipertz SL; Wang X; Beste LA
    Dig Dis Sci; 2018 Jun; 63(6):1454-1462. PubMed ID: 29453610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment and utilization of rapid virologic response in US veterans with chronic hepatitis C: evaluating provider adherence to practice guidelines.
    Hwang EW; Thomas IC; Cheung R; Backus LI
    J Clin Gastroenterol; 2013 Mar; 47(3):264-70. PubMed ID: 23269309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers to hepatitis C treatment in the era of direct-acting anti-viral agents.
    Lin M; Kramer J; White D; Cao Y; Tavakoli-Tabasi S; Madu S; Smith D; Asch SM; El-Serag HB; Kanwal F
    Aliment Pharmacol Ther; 2017 Nov; 46(10):992-1000. PubMed ID: 28949020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curing Hepatitis C Virus Infection: Best Practices From the U.S. Department of Veterans Affairs.
    Belperio PS; Chartier M; Ross DB; Alaigh P; Shulkin D
    Ann Intern Med; 2017 Oct; 167(7):499-504. PubMed ID: 28973196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study.
    Zullig LL; Bhatia HL; Gellad ZF; Eatherly M; Henderson R; Bosworth HB
    BMC Health Serv Res; 2019 Jul; 19(1):521. PubMed ID: 31345218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing access for veterans with hepatitis C by enhancing use of clinical pharmacy specialists.
    Ourth HL; Groppi JA; Morreale AP; Jorgenson T; Himsel AS; Jacob DA
    J Am Pharm Assoc (2003); 2019; 59(3):398-402. PubMed ID: 30853345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C Care in the Department of Veterans Affairs: Building a Foundation for Success.
    Belperio PS; Chartier M; Gonzalez RI; Park AM; Ross DB; Morgan TR; Backus LI
    Infect Dis Clin North Am; 2018 Jun; 32(2):281-292. PubMed ID: 29778256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary care provider perceptions and experiences of implementing hepatitis C virus birth cohort testing: a qualitative formative evaluation.
    Yakovchenko V; Bolton RE; Drainoni ML; Gifford AL
    BMC Health Serv Res; 2019 Apr; 19(1):236. PubMed ID: 31014322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment adherence and virological response rates in hepatitis C virus infected persons treated with sofosbuvir-based regimens: results from ERCHIVES.
    Butt AA; Yan P; Shaikh OS; Chung RT; Sherman KE;
    Liver Int; 2016 Sep; 36(9):1275-83. PubMed ID: 26928927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Race and Gender Differences in the Use of Direct Acting Antiviral Agents for Hepatitis C Virus.
    Kanwal F; Kramer JR; El-Serag HB; Frayne S; Clark J; Cao Y; Taylor T; Smith D; White D; Asch SM
    Clin Infect Dis; 2016 Aug; 63(3):291-9. PubMed ID: 27131869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adding ribavirin to newer DAA regimens does not affect SVR rates in HCV genotype 1 infected persons: results from ERCHIVES.
    Butt AA; Yan P; Marks K; Shaikh OS; Sherman KE;
    Aliment Pharmacol Ther; 2016 Oct; 44(7):728-37. PubMed ID: 27459341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. User experience of a hepatitis c population management dashboard in the Department of Veterans Affairs.
    Yakovchenko V; Jacob DA; Rogal SS; Morgan TR; Rozenberg-Ben-Dror K
    PLoS One; 2023; 18(5):e0285044. PubMed ID: 37130107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES.
    Butt AA; Yan P; Bonilla H; Abou-Samra AB; Shaikh OS; Simon TG; Chung RT; Rogal SS;
    Hepatology; 2015 Aug; 62(2):365-74. PubMed ID: 25847403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating Hepatitis C in Individuals With Previous Incarceration: The Veterans Health Administration, 2012-2019.
    Hawks L; Wang EA; Butt AA; Crystal S; Keith McInnes D; Re VL; Cartwright EJ; Puglisi LB; Haque LYK; Lim JK; Justice AC; McGinnis KA
    Am J Public Health; 2023 Feb; 113(2):162-165. PubMed ID: 36480765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited success of HCV antiviral therapy in United States veterans.
    Cawthorne CH; Rudat KR; Burton MS; Brown KE; Luxon BA; Janney CG; Fimmel CJ
    Am J Gastroenterol; 2002 Jan; 97(1):149-55. PubMed ID: 11808940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional and Rural-Urban Differences in the Use of Direct-acting Antiviral Agents for Hepatitis C Virus: The Veteran Birth Cohort.
    Njei B; Esserman D; Krishnan S; Ohl M; Tate JP; Hauser RG; Taddei T; Lim J; Justice AC
    Med Care; 2019 Apr; 57(4):279-285. PubMed ID: 30807449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Treatments Have Changed the Game: Hepatitis C Treatment in Primary Care.
    Facente SN; Burk K; Eagen K; Mara ES; Smith AA; Lynch CS
    Infect Dis Clin North Am; 2018 Jun; 32(2):313-322. PubMed ID: 29778258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.